Dr Reddy's receives two USFDA observations for New York API...

Dr Reddy's receives two USFDA observations for New York API facility

Posted

110

Dr. Reddy's Laboratories faced USFDA scrutiny at its New York API facility, receiving a Form 483 with two observations after a GMP inspection concluded on May 16, 2025. The company will address these concerns within the given timeframe.

Read Full Article

Effettua l'accesso per mettere mi piace, condividere e commentare!

International

Congo's coltan miners dig for world's tech; struggle regardless who is in charge

Rubaya mines in Congo are rich in coltan, essential for electronics. Armed groups control the...

By 0 2

Sports

'Letting go is not appreciated in our country': Sanjay Bangar on Virat Kohli

Virat Kohli's unexpected retirement from Test cricket has elicited varied reactions, with former...

By 0 3

Business

India clamps down on Bangladesh imports as Dhaka tilts towards China: GTRI

India has imposed import restrictions on goods from Bangladesh via land ports, potentially...

By 0 7

National

'Shashi Tharoor is looking for berth in BJP's sleeping cells inside Congress': CPI Kerala slams Lok Sabha MP

By 0 6

National

India-Pakistan row: Army confirms no DGMO-level talks today, says 'no expiry date' of ceasefire

By 0 6